Genzyme Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Genzyme Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7073
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosis I, multiple sclerosis, Gaucher disease type 1, long-term enzyme replacement therapy, acute lymphoblastic leukemia, atopic dermatitis, management of uric acid levels, fabry disease, rheumatoid arthritis, Pompe disease, non-Hodgkin’s lymphoma, multiple myleoma, gastric adenocarcinoma and squamous cell carcinoma, and kidney transplant acute rejection. The company has several more products in various stages of development. It operates a research and development lab and manufacturing plants in the US, Belgium and Ireland. The company has presence across the world. Genzyme is headquartered in Massachusetts, the US.

Genzyme Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genzyme Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genzyme Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genzyme Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genzyme Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Genzyme Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genzyme Corp, Medical Equipment, Deal Details 10
Merger 10
Sanofi Japan and Genzyme Japan Merge 10
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 11
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 12
Equity Offering 13
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 13
Genzyme Corp – Key Competitors 14
Genzyme Corp – Key Employees 15
Genzyme Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Genzyme Corp, Medical Equipment, Key Facts 2
Genzyme Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genzyme Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genzyme Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genzyme Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genzyme Corp, Deals By Market, 2012 to YTD 2018 8
Genzyme Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sanofi Japan and Genzyme Japan Merge 10
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 11
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 12
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 13
Genzyme Corp, Key Competitors 14
Genzyme Corp, Key Employees 15
Genzyme Corp, Other Locations 16
Genzyme Corp, Subsidiaries 16
Genzyme Corp, Joint Venture 18

List of Figures
Genzyme Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genzyme Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genzyme Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Genzyme Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genzyme Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genzyme Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Genzyme Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genzyme Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Genzyme Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Maistra d.d.:企業の戦略・SWOT・財務情報
    Maistra d.d. - Strategy, SWOT and Corporate Finance Report Summary Maistra d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Zain Group:企業の戦略・SWOT・財務情報
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Waters Corporation (WAT)-医療機器分野:企業M&A・提携分析
    Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatograp …
  • EWE AG:石油・ガス:M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • Jordan Ahli Bank PSC:企業の戦略・SWOT・財務分析
    Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report Summary Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Press Ganey Associates Inc:企業の戦略的SWOT分析
    Press Ganey Associates Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Central Bank of Egypt:企業の戦略的SWOT分析
    Central Bank of Egypt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Novotech (Australia) Pty Ltd (Novotech) is a contract research organization that offers clinical development services. The organization’s services include clinical trials, data management, biostatistics analysis, audits, regulatory affairs, medical writing, site management and commercializat …
  • Vygon SA-医療機器分野:企業M&A・提携分析
    Summary Vygon SA (Vygon) is a medical specialty company that designs, manufactures and markets single use medical and surgical products. It offers products in the areas of paediatrics and neonatology, emergency and intensive care units, anaesthesia, support for post-operative pain relief, vascular a …
  • Amsted Industries Inc:企業の戦略・SWOT・財務分析
    Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nippon Light Metal Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Light Metal Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Light Metal Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Colonial Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Colonial Pipeline Co (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services including …
  • G4S plc:企業のM&A・事業提携・投資動向
    G4S plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's G4S plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Braxton Technologies LLC:企業の戦略・SWOT・財務分析
    Braxton Technologies LLC - Strategy, SWOT and Corporate Finance Report Summary Braxton Technologies LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Indeck Energy Services Inc:企業の発電所・SWOT分析2018
    Indeck Energy Services Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Alabama Municipal Electric Authority:電力:M&Aディール及び事業提携情報
    Summary Alabama Municipal Electric Authority (AMEA) is a not-for-profit publicly-owned electric utility that generates, procures, and supplies power. The authority generates electricity from sources such as gas and solar. AMEA procures electricity from open market and South Carolina Public Service A …
  • Manulife Financial Corporation:企業のM&A・事業提携・投資動向
    Manulife Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Manulife Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • IGas Energy PLC (IGAS):企業の財務・戦略的SWOT分析
    IGas Energy PLC (IGAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Adamas Pharmaceuticals Inc (ADMS):企業の財務・戦略的SWOT分析
    Adamas Pharmaceuticals Inc (ADMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Avaya Inc.:戦略・SWOT・企業財務分析
    Avaya Inc. - Strategy, SWOT and Corporate Finance Report Summary Avaya Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆